Article
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.
Journal of the National Cancer Institute - 23 Feb 2015
Ng Charlotte K Y, Schultheis Anne M, Bidard Francois-Clement, Weigelt Britta, Reis-Filho Jorge S
Abstract excerpt
Rapid advancements in massively parallel sequencing methods have enabled the analysis of breast cancer genomes at an unprecedented resolution, which have revealed the remarkable heterogeneity of the disease. As a result, we now accept that despite originating in the breast, estrogen receptor (ER)-positive and ER-negative breast cancers are completely different diseases at the molecular level. It has become...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
